Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.

The role of water in kidney health extends far beyond basic hydration. As the body's primary filtration system, the kidneys depend on adequate water intake to ...

Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

While we do complain, do we really comprehend the risk it runs ... when one is diagnosed with kidney diseases, fatigue is induced due to major factors: Decreased Red Blood Cells: The kidneys ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Using the weight fluctuation data, researchers examined six criteria for kidney function decline and progression towards chronic kidney disease ... Potential Risk Factors of Body-Weight Cycling ...

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.